Answers are grounded in this paper and cite their sources.
Objective. To assess the significance of the influence of arterial hypertension (AH) and coronary artery disease (CAD) on the course and outcome of the novel coronavirus infection in patients of different age groups. Materials and methods: The study included 808 patients with COVID‑19, 452 men and 356 women, hospitalized in the intensive care unit of the infectious diseases department of the N.V. Sklifosovsky Research Institute for Emergency Medicine during the period from 01.10 to 21.12.2020. Patients were divided into groups according to age: young (18–45 years, n=121), middle-aged (46–60 years, n=268), elderly (61–75 years, n=314), and senile (over 75 years, n=105). In all patients, stage II and III AH, CAD with angina pectoris, previous and acute myocardial infarction were taken into account; indicators of clinical and laboratory studies, electrocardiography, echocardiography, and computed tomography (CT) of the chest organs were evaluated considering the degree of lung involvement. In 110 deceased patients, the severity of lung involvement and the immediate cause of death were assessed. Results. Of the total number of hospitalized patients, those of young, middle-aged, elderly, and senile age accounted for 15 %, 33%, 39%, and 13%, respectively. Among patients under 45 years of age, 68% had no concomitant pathology, 24% had stage II AH and 5% stage III AH, and only isolated patients had chronic and acute forms of CAD. In the age group of 45–60 years, the number of patients without cardiovascular diseases (CVD) decreased to 41%, those with stage II and III AH increased to 33% and 17%, and those with chronic and acute forms of CAD accounted for 6% and 3%. In the age group of 60–75 years, patients without CVD accounted for only 16%, those with stage II and III AH 43% and 17%, and those with chronic and acute forms of CAD17% and 7%, respectively. Finally, among people older than 75 years, only isolated patients had no concomitant pathology; those with stage II and III AH accounted for 40% and 19%, and the number of individuals with acute and chronic forms of CAD increased significantly to 23% and 16%, respectively. Analysis of the influence of the age factor on mortality revealed a statistically significant relationship: in the age groups under 45, 46–60, 61–75, and over 75 years the rates were 3.3%, 9.3%, 15.0%, and 32.4%, respectively. The mortality rate demonstrated an exponential increase with increasing age, which may be associated with a relatively uniform distribution of patients with AH across all age groups, while patients with CAD were predominantly represented among elderly and senile individuals. Conclusion. Age is one of the key factors determining the mortality rate in COVID‑19; however, its determining role is indirect. The extent of lung involvement and the severity of concomitant AH and CAD exert a direct influence on the course and outcome of coronavirus infection. With increasing patient age, not only is there an increase in the frequency of subtotal lung involvement, but also an accumulation of severe stages and forms of AH and CAD complicated by circulatory failure. The risk of a fatal outcome, increasing exponentially with each decade of life, is determined by the stage of AH, the form of CAD, and the degree of severity of heart failure.
No takes yet. Share an insight, caveat, or question.
Умаровна et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: